Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use STALEVO safely and effectively. See full prescribing information for STALEVO. STALEVO® (carbidopa, levodopa and entacapone) tablets, for oral useInitial U.S. Approval: 2003
Medication labelWhy this: Advisory · dailymed-prescription
Stalevo is indicated for the treatment of Parkinson's disease. Stalevo can be used: To substitute (with equivalent strengths of each of the three components) carbidopa/levodopa and entacapone previously administered as individual products. To replace carbidopa/levodopa therapy (without entacapone) when patients experience the signs and symptoms of end-of-dose "wearing-off" and when they have been taking a total daily dose of levodopa of 600 mg or less and have not been experiencing dyskinesias.
- generic_name
- carbidopa, levodopa, and entacapone
- product_names
- carbidopa, levodopa, and entacapone
- ndc
- 52427-805, 52427-805-01, 52427-809, 52427-809-01, 52427-816, 52427-816-01, 52427-827, 52427-827-01, 52427-834, 52427-834-01, 52427-842, 52427-842-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en